1-3 of 3
Michele Donato, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Transplant Outcomes after Topotecan-Melphalan-Cyclophosphamide (TMC) Conditioning for Autologous Stem Cell Transplantation for Multiple Myeloma. Comparison to Melphalan 200 mg/M2 (MEL200).

Michele Donato, MD, Ana Aleman, MD, Donna Weber, MD, Michael Wang, MD, Muzaffer Qazilbasch, MD, Marilyn Davis, R.N., Linda Roden, MD, Floralyn Mendoza, BS, Richard Champlin, MD, Sergio Giralt, MD
Journal: Blood
Blood (2005) 106 (11): 1177.
https://doi.org/10.1182/blood.V106.11.1177.1177
Published: 2005
Journal Articles

Natural History of AML / MDS Relapsing after Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Using Reduced Intensity (RIC) Preparative Regimens.

Betul Oran, MD, Sergio Giralt, MD, Munir Shahjahan, MD, Athanasios Anagnostopoulos, MD, Daniel Couriel, MD, Partow Kebriaei, MD, Chitra Hosing, MD, Shubhra Ghosh, MD, Ernesto de Meis, MD, Michele Donato, MD, Touch Ativivas, MD, Antonio Carrasco-Yalan, MD, Richard Champlin, MD, Marcos de Lima, MD
Journal: Blood
Blood (2005) 106 (11): 2019.
https://doi.org/10.1182/blood.V106.11.2019.2019
Published: 2005
Journal Articles

Allogeneic Stem Cell Transplantation with Reduced-Intensity, Fludarabine-Based Conditioning in Relapsed and Refractory Hodgkin’s Disease: Low Transplant-Related Mortality and Impact of Intensity of Conditioning Regimen on Survival.

Paolo Anderlini, MD, Rima Saliba, PhD, Michele Donato, MD, Sergio Giralt, MD, Borje Andersson, MD, Nato T. Ueno, MD, Issa F. Khouri, MD, Marcos de Lima, MD, Cindy Ippoliti, PharmD, Richard E. Champlin, MD
Journal: Blood
Blood (2004) 104 (11): 2135.
https://doi.org/10.1182/blood.V104.11.2135.2135
Published: 2004